Cancer Research Landon Prizes for Basic and Translational Cancer Research  Tumor Immunology: New Perspectives
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 48, 1110-1118, March 1, 1988]
© 1988 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Mansfield, B. K.
Right arrow Articles by Selkirk, J. K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mansfield, B. K.
Right arrow Articles by Selkirk, J. K.

Two-Dimensional Gel Electrophoretic Analysis of Cytoplasmic Proteins from Friend Erythroleukemia Cells Chemically Induced to Undergo Terminal Erythroid Differentiation1

Betty K. Mansfield, Reinhold C. Mann and James K. Selkirk2

Biology Division [B. K. M.] and Engineering Physics and Mathematics Division [R. C. M.], Oak Ridge National Laboratory, Oak Ridge, Tennessee 37831 and National Institute of Environmental Health Sciences, Research Triangle Park, North Carolina 27709 [J. K. S.]

The proerythroblastoid Friend erythroleukemia cell (FELC) line, clone TR 19-9, was treated with 4 mM hexamethylene bisacetamide (HMBA) over a 6-day period. Greater than 94% of the FELC reacted positively to the benzidine assay for hemoglobin by Day 4 of treatment. Protein accumulation during the final 4 days of treatment (from Days 2 to 6) was monitored by labeling for 24-h periods with a 14C-labeled amino acid mixture. At the end of each radiolabeling time point, cells were harvested and cytoplasmic proteins were isolated and subjected to two-dimensional gel electrophoresis in triplicate. Short-term fluorographic exposures were made in the linear X-ray film response range to monitor those polypeptides which were most rapidly accumulated. Fluorographs were digitized for computer image analysis and gel data comparison rationales were used to combine the polypeptides contained on the replicate fluorographs into a single cytoplasmic polypeptide profile or Master Image for each of the two experimental conditions, control and HMBA-treated FELC. These two images were merged into a single Master Composite Image containing a total of 211 polypeptides so that those polypeptides common to both and/or unique to each of the experimental conditions could be viewed graphically in the same plane. A total of 98 polypeptides in HMBA-treated FELC were shown to have large accumulation rate differences from the control FELC; 32 of these polypeptides were present in the HMBA Master Image which were not detected in the Control Master Image and 66 polypeptides were present in the Control Master Image but not detected in the HMBA Master Image. Five polypeptides, found in both Master Images, were shown to vary quantitatively in the HMBA-treated FELC from the corresponding polypeptides in the control. These quantitative data measurements on the rates of accumulation of various common polypeptides offer a mode for simultaneously monitoring the kinetics of induction and repression of many gene products throughout an experimental time course.

1 Research sponsored by the Office of Health and Environmental Research, United States Department of Energy, under contract DE-AC05-840R21400 with the Martin Marietta Energy Systems, Inc. A preliminary report of this work has been presented at the 78th Annual Meeting of the American Association for Cancer Research, Atlanta, GA, May 20–23, 1987 (1). This work was conducted for the National Toxicology Program under the National Institute of Environmental Health Sciences, Interagency Agreement No. Y01-ES-60151, DOE No. 40-1669-85.

2 To whom requests for reprints should be addressed, at Carcinogenesis and Toxicology Evaluation Branch, National Institute of Environmental Health Sciences, P. O. Box 12233, Research Triangle Park, NC 27709.

Received 8/19/87. Revised 11/19/87. Accepted 11/30/87.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1988 by the American Association for Cancer Research.